Enazadrem, with the CAS number 107361-33-1, is a chemical compound that has garnered attention in the field of pharmacology, particularly for its potential therapeutic applications. It is classified as a selective serotonin receptor modulator, which suggests that it interacts specifically with serotonin receptors in the brain, potentially influencing mood and anxiety levels. The compound's structure features a unique arrangement of atoms that contributes to its biological activity, making it a subject of interest in research related to mental health disorders. Enazadrem has been investigated for its effects on sleep regulation and may offer benefits in treating conditions such as insomnia or anxiety. Its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion, are critical for understanding its efficacy and safety profile. As with many compounds in this category, ongoing studies aim to elucidate its mechanism of action and potential side effects, ensuring that it can be used effectively in clinical settings.

Enazadrem

107361-33-1: Enazadrem, with the CAS number 107361-33-1, is a chemical compound that has garnered attention in the field of pharmacology, particularly for its potential therapeutic applications. It is classified as a selective serotonin receptor modulator, which suggests that it interacts specifically with serotonin receptors in the brain, potentially influencing mood and anxiety levels. The compound's structure features a unique arrangement of atoms that contributes to its biological activity, making it a subject of interest in research related to mental health disorders. Enazadrem has been investigated for its effects on sleep regulation and may offer benefits in treating conditions such as insomnia or anxiety. Its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion, are critical for understanding its efficacy and safety profile. As with many compounds in this category, ongoing studies aim to elucidate its mechanism of action and potential side effects, ensuring that it can be used effectively in clinical settings.

<p>Enazadrem is a lipoxygenase inhibitor that has been shown to be effective in inhibiting the production of prostaglandin E2. It also has been shown to modulate the release of arachidonic acid and inhibit the release of leukotrienes, thereby reducing inflammation. Enazadrem is used as a pharmaceutical preparation for the treatment of nonsteroidal anti-inflammatory drugs, such as ibuprofen, diclofenac, and indomethacin. The drug may also be used for other medical conditions where inflammation is present. It can be administered orally or by injection.</p>

<p>Enazadrem is a 5-lipoxygenase inhibitor with antiinflammatory activities.</p>

CAS 107361-33-1

Enazadrem

Enazadrem

Ref: 3D-HEA36133

Enazadrem

Ref: TM-T11196